KNOWLEDGE, ATTITUDE, AND THE PREVALENCE OF COVID-19 VACCINE BOOSTER DOSES AMONG ADULTS IN BINH DUONG PROVINCE IN 2022

Minh Chín Huỳnh 1,, Hồng Chương Nguyễn1, Nguyễn Đăng Khoa Lê1, Anh Phi Huỳnh1
1 Binh Duong Department of health

Main Article Content

Abstract

Background: Developing a safe and effective vaccine and vaccination scale-up is the safest and most promising approach to effectively and sustainably prevent COVID-19. COVID-19 vaccination protects individuals from COVID-19 and establishes herd immunity and has broad benefits at the social level in terms of increased production and positive financial impact. Objectives: The research was carried out with three goals in mind: (1). Description of knowledge on COVID-19 vaccine booster shots (2). Description of attitudes on COVID-19 vaccine booster shots (3). To determine the percentage of people who received a booster dose of COVID-19 vaccine in Binh Duong province. Materials and method: A cross-sectional study of 2140 persons aged 18 and higher in Binh Duong province was conducted. Results: Through the study, there were 14/14 questions about knowledge, with over 50% of people having correct knowledge; 9/9 questions about attitude; 80% of people have a positive attitude. The rate of vaccination against COVID-19 booster dose was 76.4%. Conclusion: It is necessary to continue to carry out communication and education activities on the effects of vaccines and the benefits of booster shots. At the same time, it is necessary to review and provide a repeat vaccination schedule for COVID-19 that is suitable for each person in the province.

Article Details

References

1. Bộ Y tế (2021), "Công văn số 10225/BYT-DP ngày 01 tháng 12 năm 2021 về việc tiêm vắc xin phòng COVID-19 liều cơ bản và nhắc lại",
2. N. Dauby (2020), "Societal impact of vaccination : beyond individual protection. Renewed interest following COVID-19 pandemic ?", Rev Med Liege, Impact sociétal de la vaccination : au-delà de la protection individuelle. Regain d’intérêt face à la pandémie COVID-19 ?, 75 (S1), 170-175.
3. M Alzyood, D Jackson, H Aveyard, J Brooke (2020), "COVID-19 reinforces the importance of handwashing", 29, 2760-2761.
4. Joseph Yuen Juin Cheng, Shaun Seh Ern Loong, Clare Elisabeth Si Min Ho, Kai Jing Ng, Miki Min Qi Ng, Ryan Choon Hoe Chee, et al. (2022), "Knowledge, Attitudes, and Practices of COVID-19 Vaccination among Adults in Singapore: A Cross-Sectional Study %J The American Journal of Tropical Medicine and Hygiene", 107 (3), 540-550.
5. VCC Cheng, SC Wong, KKW To, PL Ho, KY Yuen (2020), "Preparedness and proactive infection control measures against the emerging novel coronavirus in China", 104, 254-255.
6. J Howard (2021), "An evidence review of face masks against COVID-19", 118, e2014564118.
7. N. Barda, N. Dagan, C. Cohen, M. A. Hernán, M. Lipsitch, I. S. Kohane, et al. (2021), "Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study", Lancet, 398 (10316), 2093-2100.
8. N. Doria-Rose, M. S. Suthar, M. Makowski, S. O'Connell, A. B. McDermott, B. Flach, et al. (2021), "Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19", N Engl J Med, 384 (23), 2259-2261.
9. E. J. Haas, F. J. Angulo, J. M. McLaughlin, E. Anis, S. R. Singer, F. Khan, et al. (2021), "Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data", Lancet, 397 (10287), 1819-1829.
10. S. H. Hodgson, K. Mansatta, G. Mallett, V. Harris, K. R. W. Emary, A. J. Pollard (2021), "What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2", Lancet Infect Dis, 21 (2), e26-e35.